• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Neuronal PAS domain-containing protein 3 (NPAS3), Truncated

ACP15054

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15054 Target NameNPAS3
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8IXF0
Background Information
  • Uniprot Id

    Q8IXF0

  • Target Species

    Human

  • Target Name

    NPAS3

  • Target Full Name

    Neuronal PAS domain-containing protein 3

  • Target Function

    May play a broad role in neurogenesis. May control regulatory pathways relevant to schizophrenia and to psychotic illness.

  • Target Involvement

    A chromosomal aberration involving NPAS3 is found in a family with schizophrenia. Translocation t(9;14)(q34;q13).

  • Target Subcellular Location

    Nucleus.

  • Target Tissue Specificity

    Ubiquitously expressed in the adult brain.

  • Target Synonyms

    Basic helix loop helix PAS protein MOP6 ; Basic-helix-loop-helix-PAS protein MOP6; bHLHe12; Class E basic helix-loop-helix protein 12; FLJ10003; FLJ11138; FLJ11605; Member of PAS protein 6; MOP 6; MOP6; Neuronal PAS domain containing protein 3; Neuronal PAS domain protein 3; Neuronal PAS domain-containing protein 3; Neuronal PAS3; NPAS 3; NPAS3; NPAS3_HUMAN; PAS domain-containing protein 6; PASD 6; PASD6

Inquire Recombinant Human Neuronal PAS domain-containing protein 3 (NPAS3), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification